previous studies have suggested that the sulphonylurea hypoglycaemic agent gliclazide has specific effects in inhibiting platelet aggregation , and other haemorrheological effects that could be beneficial in preventing diabetic microangiopathy .
C0038766
sulphonylurea
C0017631
gliclazide